From Yahoo Finance: 2025-04-30 20:11:00

• Corcept Therapeutics Inc. (NASDAQ:CORT) is compared to other growth stocks for the next 3 years.
• Dan Ives of Wedbush Securities discusses tech sector outlook and AI revolution on CNBC.
• Michael Darda believes in AI’s future returns, with Dan Ives agreeing due to advancements and importance for companies.
• Despite tariffs uncertainty, demand for software remains high, especially from hyperscale companies.
• Corcept Therapeutics Inc. (NASDAQ:CORT) is a leading growth stock, with a focus on Cushing’s syndrome treatments and AI projects.
• The company submitted an NDA for relacorilant, projecting significant revenue growth in 2025.
• ClearBridge Small Cap Strategy praises Corcept’s performance and outlook in the health care sector.
• CORT ranks 15th among top growth stocks, with a focus on AI stocks for higher returns.

Read more at Yahoo Finance: Is Corcept Therapeutics Inc. (NASDAQ:CORT) the Best Growth Stock to Buy for the Next 3 Years?